Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction

BACKGROUND: The benefit of ivabradine as an adjunctive therapy to conventional treatment in patients with heart failure (HF) with reduced ejection fraction (HFrEF) is a reduction in both cardiovascular death and HF hospitalization. This study aimed to analyze the cost-effectiveness of ivabradine plu...

Descripción completa

Detalles Bibliográficos
Autores principales: Krittayaphong, Rungroj, Yadee, Jirawit, Permsuwan, Unchalee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901001/
https://www.ncbi.nlm.nih.gov/pubmed/31824183
http://dx.doi.org/10.2147/CEOR.S226568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901001/
https://www.ncbi.nlm.nih.gov/pubmed/31824183
http://dx.doi.org/10.2147/CEOR.S226568

Ejemplares similares